Subject: 🔥OTCQB: MITI Leadership Lays Out 2021 Nationwide Expansion Plan in New Interview🔥

BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.

MITI is on High Alert as Support Grows at these Levels - CHECK OUT THE CHART!

Mitesco Inc. (OTCQB: MITI)


Last:


Price: .47


Change (%): + .01 (2.17)


Volume: 1,440,000

Chart

Larry Diamond, CEO of Mitesco, Inc. and Michael Howe, CEO of The Good Clinic, are Featured in a New Audio Interview with SmallCapVoice.com

Interview provides insights and excitement surrounding MITI’s new clinic subsidiary “The Good Clinic (TM)” and the opening of its flagship unit in Minneapolis and outlook for overall company performance in 2021.

AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announced the availability of a recent interview with the leadership of Mitesco, Inc. (OTCQB: MITI) and The Good Clinic. The interview outlines the development of MITI’s team of experts, the development of The Good Clinic model, the evolution of the Company to date, and the goals for Q1 2021 and beyond.


Speaking with SCV’s Stuart Smith, Diamond and Howe explain the genesis and story behind the recent opening of its flagship location in the Norhaus apartment complex in Minneapolis, MN and the foundation built in 2020. In 2020, amidst a global pandemic, the Company was able to focus on solidifying and establishing a team of experts that made this launch possible. Mitesco believes The Good Clinic was made perfectly for occurrences like COVID. With the current health care model not fitting the needs of consumers, The Good Clinic will be providing access to comprehensive primary care via telehealth and in-neighborhood clinics. The Good Clinic’s combined digital and in-person approach to care is essential for patients in 2021 and beyond and seamlessly addresses the widespread shortage of expert primary care.


Continue Reading

Need help getting the word out on your small or micro cap stock?
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.
About Penny Stocks

Powered by:
GetResponse